Skip to main content

Table 5 Final diagnoses across the patient clusters.

From: Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data

patient clusters

final diagnosis categories

total

 

no diagnosis

benign pathologies

stones and/orinflammation

BPE

other cancers

NMI UC

MI UC

 

blue

16

1

6

6

0

26

2

57

red

3

0

1

1

0

5

3

13

green

14

5

6

4

2

17

1

49

purple

0

0

0

1

3

7

4

15

gold

3

0

4

0

1

7

8

23

  1. BPE, benign prostate enlargement; MI UC, muscle invasive urothelial cancer; NMI UC, non-muscle invasive urothelial cancer.